Risk Assessment for Epithelial Ovarian Cancer (YouTube Video #436)
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
What happens when there’s no reliable screening test for one of the deadliest cancers women face? In this episode, Dr. Barbara “Menopause” Taylor explores the complicated world of risk assessment for epithelial ovarian cancer—and why doctors are still struggling to identify which ovarian masses are truly dangerous.
From CA-125 and ultrasound scans to newer tools with names like ROCA and ROMA, Dr. Taylor breaks down the science, the limitations, and the frustrating reality that many of these tests still fall short. Along the way, she asks a bold question: are modern medicine’s attempts to combine imperfect tools just “two wrongs trying to make a right”?
If you’ve ever wondered how doctors decide whether an ovarian mass is benign or malignant, this episode delivers a fascinating behind-the-scenes look at the challenges, controversies, and high-stakes decisions involved.
Visual learner? Find the corresponding Menopause Taylor YouTube video here.
Click here for more about one-on-one consultations and Dr. Taylor's menopause resources.
Looking for a roadmap to successful menopause management? Dr. Taylor's new ebook, How to Win at Menopause: A Guide to Raising - and Winning- Your Game Your Way, will bring confidence and clarity to your menopause journey. Avoid common pitfalls and learn to navigate a healthcare system that focuses more on disease than prevention, where many professionals lack the relevant education and/or the motivation to help you.